Keke Nie
127 Si Liu South Road
Qingdao, 266042, China
Qingdao, 266042, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Targeting MET and KRAS G12C co-occurring mutation in metastatic adenoid cystic carcinoma of the trachea: a case report.
Journal: Journal of medical case reports
Published: November 28, 2024
Afatinib Combined with Bevacizumab in the Treatment of Patients with Non-Small Cell Lung Cancer Harboring EGFR G719X, S768I or L861Q/P Mutations.
Journal: International journal of general medicine
Published: July 04, 2024
Prognostic Factors and Outcomes in Advanced Stage Lung Cancer Patients with COVID-19 Omicron Variant Infection.
Journal: International journal of general medicine
Published: August 24, 2023
Osimertinib combined with bevacizumab as the first-line treatment in non-small cell lung cancer patients with brain metastasis harboring epidermal growth factor receptor mutations.
Journal: Thoracic cancer
Published: February 15, 2023
S-1 Maintenance Therapy in Extensive Stage Small-Cell Lung Cancer-A Randomized Clinical Study.
Journal: Cancer control : journal of the Moffitt Cancer Center
Published: June 20, 2020
Irinotecan combined with oxaliplatin and S-1 in patients with metastatic pancreatic adenocarcinoma: a single-arm, three-centre, prospective study.
Journal: Therapeutic advances in medical oncology
Published: April 13, 2020
A randomized clinical study to compare intrapleural infusion with intravenous infusion of bevacizumab in the management of malignant pleural effusion in patients with non-small-cell lung cancer.
Journal: Thoracic cancer
Published: September 23, 2019
Risk Factors for Esophageal Fistula in Esophageal Cancer Patients Treated with Radiotherapy: A Systematic Review and Meta-Analysis.
Journal: Oncology research and treatment
Published: December 02, 2018
Primary resistance to crizotinib treatment in a non-small cell lung cancer patient with an EML4-ALK rearrangement: a case report.
Journal: Cancer biology & medicine
Published: June 29, 2018
Mutational Profiling of Non-Small-Cell Lung Cancer Resistant to Osimertinib Using Next-Generation Sequencing in Chinese Patients.
Journal: BioMed research international
Published: December 19, 2017
Osimertinib compared docetaxel-bevacizumab as third-line treatment in EGFR T790M mutated non-small-cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 30, 2017
Last Updated: 09/26/2026